182 related articles for article (PubMed ID: 29016454)
21. Age as a risk factor for steroid-induced ocular hypertension in the non-paediatric population.
Choi W; Bae HW; Choi EY; Kim M; Kim EW; Kim CY; Kim M; Seong GJ
Br J Ophthalmol; 2020 Oct; 104(10):1423-1429. PubMed ID: 32071035
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and safety of two or more dexamethasone intravitreal implant injections for treatment of macular edema related to retinal vein occlusion (Shasta study).
Capone A; Singer MA; Dodwell DG; Dreyer RF; Oh KT; Roth DB; Walt JG; Scott LC; Hollander DA
Retina; 2014 Feb; 34(2):342-51. PubMed ID: 23846381
[TBL] [Abstract][Full Text] [Related]
23. Incidence, Risk Factors, Treatment, and Outcome of Ocular Hypertension following Intravitreal Steroid Injections: A Comparative Study.
Badrinarayanan L; Rishi P; George R; Isaac N; Rishi E;
Ophthalmologica; 2022; 245(5):431-438. PubMed ID: 35468616
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of dexamethasone intravitreal implant for the treatment of diabetic macular edema.
Bonnin S; Dupas B; Sanharawi ME; Perol J; Erginay A; Tadayoni R; Massin P
Eur J Ophthalmol; 2015; 25(5):448-53. PubMed ID: 25684155
[TBL] [Abstract][Full Text] [Related]
25. Safety and Efficacy of Intravitreal Dexamethasone Implant for Refractory Uveitic Macular Edema in Adults and Children.
Ratra D; Barh A; Banerjee M; Ratra V; Biswas J
Ocul Immunol Inflamm; 2018; 26(7):1034-1040. PubMed ID: 29394119
[TBL] [Abstract][Full Text] [Related]
26. Dexamethasone implant in diabetic macular edema in real-life situations.
Chhablani J; Bansal P; Veritti D; Sambhana S; Sarao V; Pichi F; Carrai P; Massaro D; Lembo A; Mansour AM; Banker A; Gupta SR; Hamam R; Lanzetta P
Eye (Lond); 2016 Mar; 30(3):426-30. PubMed ID: 26611849
[TBL] [Abstract][Full Text] [Related]
27. Two or more dexamethasone intravitreal implants in treatment-naïve patients with macular edema due to retinal vein occlusion: subgroup analysis of a retrospective chart review study.
Dugel PU; Capone A; Singer MA; Dreyer RF; Dodwell DG; Roth DB; Shi R; Walt JG; Scott LC; Hollander DA;
BMC Ophthalmol; 2015 Sep; 15():118. PubMed ID: 26337664
[TBL] [Abstract][Full Text] [Related]
28. Elevation of intraocular pressure after inadvertent dexamethasone implant injection into the lens.
Lee K; Park A; Jang S; Chung YR
Can J Ophthalmol; 2016 Jun; 51(3):e103-5. PubMed ID: 27316280
[No Abstract] [Full Text] [Related]
29. Systemic Steroid Sparing Effect of Intravitreal Dexamethasone Implant in Chronic Noninfectious Uveitic Macular Edema.
Fabiani C; Vitale A; Emmi G; Lopalco G; Vannozzi L; Bacherini D; Guerriero S; Favale RA; Fusco F; Franceschini R; Frediani B; Iannone F; Galeazzi M; Tosi GM; Cantarini L
J Ocul Pharmacol Ther; 2017 Sep; 33(7):549-555. PubMed ID: 28557602
[TBL] [Abstract][Full Text] [Related]
30. Treatment of anti-vascular endothelial growth factor-resistant diabetic macular edema with dexamethasone intravitreal implant.
Lazic R; Lukic M; Boras I; Draca N; Vlasic M; Gabric N; Tomic Z
Retina; 2014 Apr; 34(4):719-24. PubMed ID: 23975006
[TBL] [Abstract][Full Text] [Related]
31. Secondary glaucoma after intravitreal dexamethasone 0.7 mg implant in patients with retinal vein occlusion: a one-year follow-up.
Meyer LM; Schönfeld CL
J Ocul Pharmacol Ther; 2013; 29(6):560-5. PubMed ID: 23480270
[TBL] [Abstract][Full Text] [Related]
32. Use of intravitreal dexamethasone implant in patients with cataract and macular edema undergoing phacoemulsification.
Sze AM; Luk FO; Yip TP; Lee GK; Chan CK
Eur J Ophthalmol; 2015; 25(2):168-72. PubMed ID: 25363857
[TBL] [Abstract][Full Text] [Related]
33. Intraocular pressure after intravitreal injection of dexamethasone implant for macular edema resulting from retinal vein occlusion.
Caillaux V; Valtot F; Souied EH; Mimoun G
Eur J Ophthalmol; 2015; 25(5):454-8. PubMed ID: 25743778
[TBL] [Abstract][Full Text] [Related]
34. Efficacy and Safety of Intravitreal Dexamethasone Implant in Patients with Diabetic Macular Edema.
Guigou S; Pommier S; Meyer F; Hajjar C; Merite PY; Parrat E; Rouhette H; Rebollo O; Matonti F
Ophthalmologica; 2015; 233(3-4):169-75. PubMed ID: 25924737
[TBL] [Abstract][Full Text] [Related]
35. INTRAVITREAL DEXAMETHASONE IMPLANT FOR THE TREATMENT OF REFRACTORY MACULAR EDEMA IN RETINAL VASCULAR DISEASES: Results of the KKESH International Collaborative Retina Study Group.
Alshahrani ST; Dolz-Marco R; Gallego-Pinazo R; Diaz-Llopis M; Arevalo JF;
Retina; 2016 Jan; 36(1):131-6. PubMed ID: 26079477
[TBL] [Abstract][Full Text] [Related]
36. Dexamethasone intravitreal implant in vitrectomized versus nonvitrectomized eyes for treatment of patients with persistent diabetic macular edema.
Medeiros MD; Alkabes M; Navarro R; Garcia-Arumí J; Mateo C; Corcóstegui B
J Ocul Pharmacol Ther; 2014 Nov; 30(9):709-16. PubMed ID: 25259834
[TBL] [Abstract][Full Text] [Related]
37. Intravitreal Dexamethasone Implant for the Treatment of Postoperative Macular Edema.
Klamann A; Böttcher K; Ackermann P; Geerling G; Schargus M; Guthoff R
Ophthalmologica; 2016; 236(4):181-185. PubMed ID: 27915343
[TBL] [Abstract][Full Text] [Related]
38. [Early efficacy of dexamethasone implant (OZURDEX
Sarda V; Fajnkuchen F; Nghiem-Buffet S; Grenet T; Chaine G; Giocanti-Auregan A
J Fr Ophtalmol; 2017 May; 40(5):408-413. PubMed ID: 28336283
[TBL] [Abstract][Full Text] [Related]
39. Phaco-non-penetrating deep sclerectomy in ocular hypertension secondary to dexamethasone intravitreal implant.
Pérez-Sarriegui A; Casas-Llera P; Díez-Álvarez L; Contreras I; Moreno-López M; Figueroa MS; González-Martín-Moro J; Muñoz-Negrete FJ; Rebolleda G
Arch Soc Esp Oftalmol (Engl Ed); 2018 Dec; 93(12):580-585. PubMed ID: 30266279
[TBL] [Abstract][Full Text] [Related]
40. COMBINED VITRECTOMY AND INTRAVITREAL DEXAMETHASONE (OZURDEX) SUSTAINED-RELEASE IMPLANT.
Zheng A; Chin EK; Almeida DR; Tsang SH; Mahajan VB
Retina; 2016 Nov; 36(11):2087-2092. PubMed ID: 27148836
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
